| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |